PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Rubino, F.* ; Cohen, R.V.* ; Mingrone, G.* ; le Roux, C.W.* ; Mechanick, J.I.* ; Arterburn, D.E.* ; Vidal, J.* ; Alberti, G.* ; Amiel, S.A.* ; Batterham, R.L.* ; Bornstein, S.R. ; Chamseddine, G.* ; Del Prato, S.* ; Dixon, J.B.* ; Eckel, R.H.* ; Hopkins, D.* ; McGowan, B.M.* ; Pan, A.* ; Patel, A.* ; Pattou, F.* ; Schauer, P.R.* ; Zimmet, P.Z.* ; Cummings, D.E.*

Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery.

Lancet Diabet. Endocrinol. 8, 640-648 (2020)
DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
The coronavirus disease 2019 pandemic is wreaking havoc on society, especially health-care systems, including disrupting bariatric and metabolic surgery. The current limitations on accessibility to non -urgent care undermine postoperative monitoring of patients who have undergone such operations. Furthermore, like most elective surgery, new bariatric and metabolic procedures are being postponed worldwide during the pandemic. When the outbreak abates, a backlog of people seeking these operations will exist. Hence, surgical candidates face prolonged delays of beneficial treatment. Because of the progressive nature of obesity and diabetes, delaying surgery increases risks for morbidity and mortality, thus requiring strategies to mitigate harm. The risk of harm, however, varies among patients, depending on the type and severity of their comorbidities. A triaging strategy is therefore needed. The traditional weight -centric patient -selection criteria do not favour cases based on actual clinical needs. In this Personal View, experts from the Diabetes Surgery Summit consensus conference series provide guidance for the management of patients while surgery is delayed and for postoperative surveillance. We also offer a strategy to prioritise bariatric and metabolic surgery candidates on the basis of the diseases that are most likely to be ameliorated postoperatively. Although our system will be particularly germane in the immediate future, it also provides a framework for long-term clinically meaningful prioritisation.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
25.340
6.626
81
103
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Fatty Liver-disease; Y Gastric Bypass; Type-2 Diabetes Remission; Long-term Mortality; Body-mass Index; Weight-loss; Preoperative Prediction; Translating Research; Obese-patients; Risk
Sprache englisch
Veröffentlichungsjahr 2020
HGF-Berichtsjahr 2020
ISSN (print) / ISBN 2213-8587
e-ISSN 2213-8595
Zeitschrift Lancet Diabetes and Endocrinology
Quellenangaben Band: 8, Heft: 7, Seiten: 640-648 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort Ste 800, 230 Park Ave, New York, Ny 10169 Usa
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Pancreatic Islet Research (IPI)
POF Topic(s) 90000 - German Center for Diabetes Research
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-502600-007
DOI 10.1016/S2213-8587(20)30157-1
WOS ID WOS:000549557700023
Scopus ID 85084617128
PubMed ID 32386567
Erfassungsdatum 2020-06-02
[➜Korrektur melden]